TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX) Insider Trading
Directors, officers and holders of more than 10% of TCRX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 38 most recent of 38 transactions on file: 10 with code P, 0 with code S and 28 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | MacBeath Gavin | Chief Executive Officer | A Award | 1,000,000 | Not measured | Not measured |
| Oct 1, 2026 | ZDRAVESKI ZORAN | See Remarks | A Award | 300,000 | Not measured | Not measured |
| May 20, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | Klencke Barbara | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | Dorton Katina | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | Gruia Gabriela | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | Nicholson Garry A | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | Woods Keith | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 67,000 | Not measured | Not measured |
| Jan 20, 2026 | ZDRAVESKI ZORAN | See Remarks | A Award | 350,000 | Not measured | Not measured |
| Jan 20, 2026 | MacBeath Gavin | Chief Executive Officer | A Award | 1,165,000 | Not measured | Not measured |
| Jan 20, 2026 | Amello Jason | Chief Financial Officer | A Award | 350,000 | Not measured | Not measured |
| Jan 20, 2026 | Louis Chrystal | Chief Medical Officer | A Award | 420,000 | Not measured | Not measured |
| Jan 20, 2026 | Dworak Leiden | See Remarks | A Award | 100,000 | Not measured | Not measured |
| Dec 23, 2025 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 6,232 | $0.8989 | $5,602 |
| Dec 22, 2025 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 75,500 | $0.9000 | $67,950 |
| Dec 19, 2025 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 80,069 | $0.8989 | $71,974 |
| Jun 30, 2025 | BAKER BROS. ADVISORS LP | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | Gruia Gabriela | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | BAKER BROS. ADVISORS LP | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | Dorton Katina | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | Woods Keith | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | Nicholson Garry A | Director | A Award | 67,000 | Not measured | Not measured |
| Jun 30, 2025 | Klencke Barbara | Director | A Award | 67,000 | Not measured | Not measured |
| May 20, 2025 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 1,200,000 | $1.20 | $1,440,000 |
| May 19, 2025 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 1,388,794 | $1.20 | $1,666,553 |
| Jan 3, 2025 | MacBeath Gavin | Chief Executive Officer | A Award | 800,000 | Not measured | Not measured |
| Jan 3, 2025 | Louis Chrystal | Chief Medical Officer | A Award | 400,000 | Not measured | Not measured |
| Jan 3, 2025 | ZDRAVESKI ZORAN | See Remarks | A Award | 250,000 | Not measured | Not measured |
| Jan 3, 2025 | Amello Jason | Chief Financial Officer | A Award | 270,000 | Not measured | Not measured |
| Dec 26, 2024 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 7,500,000 | $4.00 | $30,000,000 |
| Dec 13, 2024 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 100,000 | $2.90 | $290,140 |
| Dec 12, 2024 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 31,800 | $3.01 | $95,629 |
| Nov 15, 2024 | Lynx1 Capital Management LP | 10% Owner | P Purchase | 947 | $4.34 | $4,114 |
| Sep 23, 2024 | Klencke Barbara | Director | P Purchase | 5,000 | $5.29 | $26,450 |
| Jan 12, 2024 | MacBeath Gavin | Chief Executive Officer | A Award | 160,000 | Not measured | Not measured |
| Jan 12, 2024 | Dworak Leiden | See Remarks | A Award | 46,875 | Not measured | Not measured |
| Jan 12, 2024 | ZDRAVESKI ZORAN | See Remarks | A Award | 52,500 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.